Merck KGaA, Biomira Shares Gain on Cancer Study (Update1) Shares of Biomira Inc., a Canadian drug developer, jumped 94 percent and Merck KGaA, Germany #39;s fourth-largest drugmaker, rose as much as 6.4 percent after the companies said data from 